NDC 0456-1228 – Namzaric
Memantine Hydrochloride 28 mg/1; Donepezil Hydrochloride 10 mg/1 · Capsule · Oral
Product NDC0456-1228
Product details
- Brand name
- Namzaric
- Generic name
- Memantine hydrochloride and donepezil hydrochloride
- Labeler
- Allergan, Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- NDA · NDA206439
- Marketed since
- December 24, 2014
- Listing expires
- December 31, 2027
- Pharmacologic class
- Cholinesterase Inhibitor; N-methyl-D-aspartate Receptor Antagonist
Active ingredients
- Memantine Hydrochloride 28 mg/1
- Donepezil Hydrochloride 10 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0456-1228-30 | 30 CAPSULE in 1 BOTTLE (0456-1228-30) | Dec 24, 2014 |
Recalls mentioning this NDC
- D-0418-2021 Jun 2, 2021 · Class II
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Other Namzaric products
- 0456-1207 Memantine Hydrochloride 7 mg/1; Donepezil Hydrochloride 10 mg/1 · Capsule · Allergan, Inc.
- 0456-1214 Memantine Hydrochloride 14 mg/1; Donepezil Hydrochloride 10 mg/1 · Capsule · Allergan, Inc.
- 0456-1221 Memantine Hydrochloride 21 mg/1; Donepezil Hydrochloride 10 mg/1 · Capsule · Allergan, Inc.